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Abstract: Marine toxins, such as saxitoxin and domoic acid are associated with algae blooms and
can bioaccumulate in shell fish which present both health and economic concerns. The ability to
detect the presence of toxin is paramount for the administration of the correct supportive care in
case of intoxication; environmental monitoring to detect the presence of toxin is also important for
prevention of intoxication. Immunoassays are one tool that has successfully been applied to the
detection of marine toxins. Herein, we had the variable regions of two saxitoxin binding monoclonal
antibodies sequenced and used the information to produce recombinant constructs that consist
of linked heavy and light variable domains that make up the binding domains of the antibodies
(scFv). Recombinantly produced binding elements such as scFv provide an alternative to traditional
antibodies and serve to “preserve” monoclonal antibodies as they can be easily recreated from their
sequence data. In this paper, we combined the anti-saxitoxin scFv developed here with a previously
developed anti-domoic acid scFv and demonstrated their utility in a microsphere-based competitive
immunoassay format. In addition to detection in buffer, we demonstrated equivalent sensitivity in
oyster and scallop matrices. The potential for multiplexed detection using scFvs in this immunoassay
format is demonstrated.
Keywords: saxitoxin; domoic acid; single chain antibody; xMAP
1. Introduction
Food poisoning from naturally occurring marine toxins is a worldwide public health issue, and
it poses economic issues/concerns for the food industry. Marine toxins, such as saxitoxin (STX) and
domoic acid (DA), are associated with algae blooms and can bioaccumulate in shellfish and herbivorous
fishes causing food poisoning [1,2]. The frequency of STX and DA producing algae blooms is on the
rise [3], possibly due to climate change, leading to increasing potential for adverse environmental,
economic, and health implications.
STXs, produced by dinoflagellates, are the most well studied cause of paralytic shellfish poisoning
(PSP) which is also the most common and lethal form of marine toxin poisoning [2,4]. PSP results in
paralysis of muscles throughout the body and at higher concentrations can cause death. STX, is a heat
stable toxin whose primary target is the voltage-gated sodium channels in the nerve and muscle cells
of the body affecting the gastrointestinal and neurological systems [4,5]. Because of its potency, STX
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has been identified as a potential biothreat agent and is regulated as a select agent by the U.S. Center
for Disease Control (CDC).
DA is a representative of toxins that cause amnesic shellfish poisoning (ASP). Besides typical
food poisoning symptoms, short term memory loss, confusion, and disorientation are observed in ASP.
Although higher levels of DA are needed for intoxication, it is a heat stable toxin that can cause kidney
damage at levels several orders of magnitude lower than those that cause neurological symptoms [5,6].
It acts by stimulating the glutamate receptors.
There is no known antidote for either STX or DA poisoning; therefore, the ability to detect the
presence of toxin is vital for the early administration of the correct supportive care [7]. Detection of
these and related toxins are also of importance for environmental monitoring to limit use of shellfish
from that region. Until the last decade, the mouse bioassay (MBA) was the only approved method
for the detection of marine toxins. The MBA provides toxicity information about the food sample
but not toxin identification. Moral and ethical issues with this method (animal usage) have led to the
development of other methods. Liquid chromatography such as HPLC (with fluorometric detection
for STX), LC-UV for DA, LC-MS and UPLC-MS/MS [2,4,8,9], are methods that are able to detect and
identify variants of the toxins. HPLC-FD and LC-UV have been validated for use in the EU. Surface
Enhanced Raman Scattering (SERS) has also been demonstrated [9,10]. While these methods have the
specificity, they require extensive sample preparation, expensive equipment, highly trained personnel,
and the availability of analytical standards. In addition, interferences from complex matrices have
been observed.
Alternatively, biologically-based assays have been developed that can monitor toxicity similar
to the MBA and, thereby, provide for rapid screening of samples. Cell-based sensors have been
developed for PSP toxins, which utilize only cells instead of animals [11–13]. In 2012, Van Dolan et al.
described a receptor-based assay that was able to detect PSP toxins near the regulatory limits [4,14].
Even though cells and receptors have been employed to identify marine toxins and their toxicity,
most bio-based methods employ antibodies as a rapid screening tool. Several different immunoassays
have successfully been applied to the detection of marine toxins that use either polyclonal (pAbs)
or monoclonal antibodies (mAbs) against STX and DA [15–19]. Antibodies have been used in many
different detection formats such as: enzyme-linked immunosorbent assays (ELISAs) [20,21], surface
plasmon resonance (SPR) [22–25], fluorescence/chemiluminescence-based microarray assays [26,27]
flow cytometry [28,29], and lab-on-a-chip using fluorescence and magnetic particles [30]. Recently, two
groups have been developing lateral flow immunoassays (LFIs) for the detection of PSP toxins and DA
as rapid, low tech screening assays [31–33]. Campbell et al. reviews biological toxin binders in detail
in their 2011 paper [34].
In the last few years, concerns have grown over the reliability and reproducibility of standard
antibodies. A. Bradbury wrote an article in Nature describing the issues with using traditional
monoclonal and polyclonal antibodies [35]. These issues include availability of antibody (polyclonals
-batch-to-batch variability), use of animals, and for monoclonals, the death of hybridoma cell lines.
A viable alternative is recombinant antibodies including single-chain variable fragment (scFv), and
single domain antibodies (sdAb) [36]. Recombinant constructs (scFv) that consist of linked heavy
and light variable domains that make up the binding domains of conventional antibodies have
been produced for the sensitive detection of DA, as well as a number of other biotoxins [37,38].
Recombinantly produced binding elements serve to “preserve” mAbs as they can be easily recreated
from their sequence information, thereby reducing variability and eliminating issues with loss of cell
lines. An additional advantage of scFv over mAbs is the ability to produce reagent recombinantly
in E. coli and the potential to produce fusion constructs with enhanced utility that can potentially be
tailored to particular sensor systems [38–41]. While not universal, improvements in stability, affinity,
and diversity have been observed in scFvs, for example, improvement in both stability and affinity
was demonstrated by McConell et al. [42].
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Herein, we demonstrate recombinantly produced antibody recognition domains, scFvs, in
a microsphere-based competitive immunoassay for the detection of STX and DA. This work utilized
the previously described anti-DA binding fragment [37] in conjunction with an anti-STX binding
domain that was synthesized from the sequence of an anti-STX mAb [15]. In addition to detection in
buffer, we show the utility of the assay in shellfish matrices.
2. Results and Discussion
2.1. Sequencing and Evaluation of Anti-STX mAbs for scFv Production
The hybridoma supernatants and cell lines for the sequencing of anti-STX mAbs 5F7 and
1E8 were developed at Ludwig-Maximilians-Universität Munich (LMU) [15]. We contracted with
Genscript (Piscataway, NJ, USA) to have the variable regions of the mAbs sequenced as well as for
the production of each mAb for evaluation. Sequencing showed that 5F7 and 1E8’s sequences were
unique (Figure 1). The mAbs were evaluated by surface plasmon resonance (SPR) for their ability
to bind to a STX-IgG-antigen (Figure 2). STX was coupled to an irrelevant human IgG (HuIgG); the
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Figure 1. Sequence of the variable heavy chain (VH) and variable light chain (VL) regions of anti-saxiton
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Figure 2. Surface plasmon resonance evaluation of anti-STX mAbs. The binding affinities of anti-STX
mAbs, 5F7 and 1E8 were each evaluated on a surface with immobilized STX-HuIgG. Each mAb was
tested simultaneously at six oncentr tions with an associat on time of 90 s and a dissociation time of
600 s. See Experimental Section for additional details.
he bs ere also sho n to function in x P assays on the PI instru ent. First, each
b was biotinylated and the dose response direct binding to STX-coated microspheres was evaluated
to determine an appropriate concentration to use for a competitive assay (not shown). Next, the two
mAbs were shown to function in a competitive format for the detection of STX (Figure 3). he results
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were very similar to those observed previously in a competitive ELISA assay [15], with 1E8 in this
format appearing to have a higher affinity for STX and providing a better limit of detection.
The use of IgG for conjugation of the STX was due to the need to have a glycosylated molecule
onto which the STX can be attached. Conjugate preparation followed a procedure that couples
through the carbohydrate of the antibody to amines on the antigen paralleling the chemistry originally
utilized for the immunogen used to prepare the mAbs [15]. STX was conjugated to IgG through
a periodate chemistry that specifically activates the carbohydrate residues (described in Section 4.6);
once activated, the aldehyde formed is highly reactive toward nucleophiles, especially primary amines.
The highly negative pI of glucose oxidase (GO) used in the mAb production makes it less suitable for
our application as it does not immobilize well onto the microspheres. The long linker length between
the protein and the immobilized STX provided by carbohydrate side chains may contribute to the
superiority of this chemistry for formation of both immunogen and toxin analog.
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Figure 3. AGPIX x AP STX co petitive i unoassay using Abs. Each Ab was biotinylated
and tested at 1 µg/ L in a co petitive assay using STX- uIgG coated agPlex beads as described
in the experi ental section. dditional control bead sets are not sho n. The graph is co piled fro
separate ST dose response assays for each of the bs.
2.2. Production of scFv Targeting STX and DA
The protein sequences of the variable heavy and light domains from anti-STX mAbs 5F7 and 1E8
were synthesized with the variable heavy domain as a NcoI-NotI fragment and the light chain with
flanking BamH1 and XhoI sites with a 26 amino acid long linker (containing the Not I and BamH1
sites) joining the two domains. The DNA for expressing the scFv was inserted, using NcoI-XhoI, to the
pET22b(+) expression vector for periplasmic protein production.
Protein yields of ~1–2 mg/L were obtained from the 5F7 scFv, however, although we tried several
times, we were unable to purify protein from the 1E8 scFv. We chose to focus on developing an anti-STX
xMAP assay utilizing the 5F7 scFv. In the future, strategies such as expression with chaperones, fusion
with a constant domain, or CDR grafting could be implemented for production of the 1E8 scFv [42–44].
For detection of DA, we were kindly provided with the protein sequence of the anti-DA scFv
DA24cB7 (Figure 1) by Dr. Marian Kane [37]. We had the gene synthesized with flanking NcoI and
XhoI restriction sites for cloning and a 15 amino acid linker between the variable heavy and light
chains. The scFv was cloned into pET22b(+) for expression and typically yielded ~5–10 mg/L.
2.3. Evaluation of scFv Targeting STX and DA
Like monoclonal and polyclonal antibodies, scFvs have been incorporated into ELISAs, SPR, and
LFIs [38]. Although the ELISA form t aff rds amplific tion through the actio f an enzyme, it is
not easily multiplexed to examine multiple toxins in one well. T e Luminex xMAP methodology
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consists of assays performed on color coded beads that can be highly multiplexed. Both sandwich
and competitive format immunoassays have been demonstrated using the Luminex system [17,45,46].
In this article, an xMAP assay monitored using a MAGPIX system for the individual detection of STX
and DA utilizing scFv recognition elements was demonstrated, Figures 4, 5, and Figure S1.
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shellfish matrices. For sample preparation of the seafood materials, a simple extraction protocol was
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utilized, however, more complex extraction methodologies that are likely more efficient have been
described [27,47]. As shown in Figure 4, the scFvs were able to detect STX or DA in all three matrices
in a dose dependent manner. Beads sets in which STX was coupled to human IgG (HuIgG) or rabbit
IgG (RbIgG) showed similar dose response curves while the curves for DA microspheres which were
prepared identically gave identical responses (Figure S1). The IC50, IC10, IC90, Min, and Max were
determined (Table 1) by fitting the dose response curves using SigmaPlot 12.0 (Systat Software, San Jose,
CA, USA) with a four-parameter logistic equation, Figure 4. Averages of the raw data are shown in
Figure 5. Cross-reactivity studies for closely related compounds were not performed for the anti-STX
scFv tested here, but have previously been examined for its parental mAb [15]. The IC10, which is the
lowest concentration that these assays can be presumed to detect, was in the low ng/mL for both STX
and DA. These limits are sufficient for most monitoring needs, but were not as sensitive as have been
reported for a number of techniques. The higher IC10 could be for a number of reasons. One is that
the concentration of antibody used in the competition assay will be inversely proportional to the IC10
observed; this allows for a more robust assay as a low concentration of antibody can lead to greater
variances in the signal generated. It is likely, that with additional optimization of the assay reagents,
improvements in sensitivity could be realized. Nonetheless, for our purposes of demonstrating these
scFv immunoreagents in an xMAP assay format, these sensitivities were respectable.
Table 1. Dose response parameters for STX and DA in spiked buffer and food matrices.
STX DA
Buffer Oyster Scallops Buffer Oyster Scallops
Min (%) 3.89 ± 0.92 2.88 ± 0.87 2.37 ± 1.13 3.67 ± 1.09 4.90 ± 2.31 3.43 ± 3.00
Max (%) 89.18 ± 1.37 85.48 ± 1.31 84.65 ± 1.86 87.24 ± 1.36 92.08 ± 2.44 97.44 ± 4.33
IC10 (ng/mL) 8.08 9.55 4.43 1.85 1.05 0.94
IC50 (ng/mL) 25.57 ± 1.56 31.91 ± 1.75 27.38 ± 2.29 6.91 ± 0.36 4.57 ± 0.47 6.93 ± 1.12
IC90 (ng/mL) 93.98 106.85 169.10 25.75 19.96 51.06
As this work only examined standard curves for the detection of STX and DA in the various oyster
and scallop extracts in comparison to a standard curve generated in buffer, extraction efficiencies
were not calculated. However, it is possible to evaluate the matrix effect’s impact on the ability to
discriminate the toxins. By comparing the magnitude of signal response in each matrix to that in buffer
and the corresponding maximum signal divided by the minimum signal (signal-to-noise, S/N), one
can estimate how the matrices affect the assays, see Table 2. The results of this analysis on the raw
data shows that for the STX assay the response is slightly reduced for the oyster matrix and degraded
~50% for the scallop matrix, but the ability to discriminate that signal based on the ratio of S/N shows
little change. For the DA assay, the signal strength is dramatically reduced in the matrices, especially
for the oyster assay, which was reduced to ~1/4 the buffer signal levels, however, when comparing
the S/N for the DA assays, the ratio actually improved in the extracts, possibly due to a reduction
in nonspecific binding. Thus, it appears that the ability to discriminate STX and DA in the seafood
extracts is not severely degraded, suggesting this minimal extraction protocol may warrant further
evaluation to determine its efficiency as compared to others [27,47].










Buffer 100 7.7 ± 3.4 100 8.8 ± 3.6
Oyster 80 ± 22 8.3 ± 2.2 23 ± 3 12.9 ± 3.2
Bay Scallops 51 ± 11 6.3 ± 1.9 50 ± 23 27 ± 11
Avg and SD of two bead sets from two separate experiments.* ((Maxmatrix − Minmatrix)/(Maxbuffer − Minbuffer)) × 100.
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2.4. Combined STX and DA Assays
Preliminary efforts to combine the two assays were also undertaken. A combined assay for STX
and DA was performed by mixing beads specific for STX and DA as well as both corresponding
biotinylated scFvs. Figure S2 shows the results for the spiked STX or DA samples. While there
is an increase in the inhibition for the STX microspheres in the DA spiked samples, there is a clear
difference in signal at the higher concentration of free DA. The corresponding assay with STX had larger
cross-reactivity issues. The cross-reactivity could be due to non-specific binding of the biotinylated
scFvs to the microspheres in the absence of antigen. Further work would be required to develop or
optimize an assay with less cross-reactivity, including blocking the beads after toxin immobilization or
adjusting the buffers and wash buffers utilized to minimize this unwanted condition.
3. Conclusions
The ability to overcome disadvantages of pAbs and mAbs (e.g., availability and animal usage) by
using recombinant constructs such as scFvs is the way of the future. In this study, we demonstrated
the use of scFvs for the detection of two marine toxins: STX and DA. We employed these scFvs
in competitive assays using the xMAP fluid array technology, obtaining limits of detection that
approached those obtained with other antibodies, although further optimization is warranted.
We demonstrated detection in both buffer and spiked food matrices with minimal sample preparation.
Using the sequence information provided herein, these recognition molecules (scFvs) are now available
to other researchers for incorporation into their immunoassay platforms as an alternative to traditional
antibodies, and they could also be further engineered to include biotin binding domains or signal
transduction domains (i.e., alkaline phosphatase) to further enhance their utility.
4. Experimental Section
4.1. Materials
MagPlex microspheres and MAGPIX Instrument were from Luminex Corporation (Austin, TX,
USA). Streptavidin–R phycoerthryin (SA-PE) was purchased from Columbia Biosciences (Frederick,
MD, USA) and the biotinylated anti-streptavidin (anti-SA) was obtained from Vector Laboratories
(Burlingame, CA, USA). Phosphate-buffered saline with Tween and BSA (PBSTB) were prepared from
phosphate-buffered saline with 0.05% Tween-20 (PBST) packets and 0.1% bovine serum albumin (BSA)
from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). The saxitoxin dihydrochloride, 100 µg/mL in
20% ethanol-water solution (pH 3), was the kind gift of Dr. Sherwood Hall, US FDA, College Park,
MD, USA. Domoic acid was purchased from Calbiochem EMD Biosciences (San Diego, CA, USA).
4.2. scFv Construction and Protein Production
The genes coding for the variable heavy and light domains from anti-STX mAbs 5F7 and 1E8
were synthesized with codons optimized for expression in E. coli (GenScript, Piscataway, NJ, USA).
The variable heavy domain was PCR amplified from the plasmid provided by Genscript with primers
that introduced flanking NcoI and NotI sites; the light chain was similarly amplified to introduce
flanking BamH1 and XhoI sites. The PCR products were digested and gel purified prior to ligation
into a pET22b derivative containing the linker sequence AAAGSGSGGGSSGGGSSGGGSGASGS,
between the NotI (coded by AAA) and the Bam H1 (coded by the C-terminal GS) sites. Similarly, the
sequence for the variable heavy and light chain of the anti-DA scFv DA24cB7, joined by a 15 amino
acid linker, was synthesized with flanking NcoI and XhoI sites (GenScript) and cloned into the pET22b
expression vector.
The anti-STX scFvs and the anti-DA scFv were grown and produced essentially as described
previously [48]. Cultures were grown at 25 or 30 ◦C in terrific broth (TB). Fifty mL overnight cultures
were used to inoculate 500 mL of TB and were grown for 3 h before induction by addition of 1 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG). After induction, cultures were grown 3 h before
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pelleting and subjected to an osmotic shock protocol [44,45]. The scFv were purified from the shockate
by immobilized metal affinity chromatography followed by size exclusion chromatography using
a Superdex 75 10/300 GL column (GE Healthcare, Pittsburgh, PA, USA) and a BioLogic Duo-Flow
Chromatography System (Bio-Rad, Hercules, CA, USA). The yield of the scFv was determined by UV
spectroscopy, measuring the absorbance at 280 nm using a NanoDrop 2000 (Thermo Fisher, Waltham,
MA, USA).
4.3. Food Matrices Preparation
A simple sample preparation protocol was used to extract the toxins as compared to the more
stringent buffer conditions described in Campbell et al. and Szkola et al. [27,47]. Bay scallops
(live, frozen) and live oysters were purchased from a local grocery store. The oysters were placed at
−20 ◦C overnight. The frozen bay scallops (200 g) were blended in a small Cuisinart food processor
until smooth with no additional liquid. The puree was placed in 15 mL centrifuge tubes (VWR, Radnor,
PA, USA) in 5 g aliquots and frozen until testing. For the frozen oysters, 120.5 g were blended with no
additional liquid, aliquoted in 5 g sizes, and frozen until testing.
Just prior to testing, the 5 g samples were thawed and 10 mL PBSTB were added. To the thoroughly
blended samples, either STX or DA were spiked to give 1000 ng/mL or 200 ng/mL, respectively.
The samples were mixed and incubated for 2 h at room temperature, then spun to remove large
particulates. The supernatant was used for analysis. Extraction efficiency was not determined.
4.4. Preparation and Biotinylation of mAbs and ScFv
The antibodies were purified from cell supernatants by MEP HyperCel hydrophobic charge
induction chromatography (Pall, East Hills, NY, USA), as described previously [49]. Antibodies and
scFvs were biotinylated using NHS-LC-LC-Biotin (Thermo-Fischer, Waltham, MA, USA) dissolved
in dimethyl sulfoxide (20 g/L). The antibodies were reacted with a 10:1 molar excess of the
NHS-LC-LC-Biotin. To enhance the rate of reaction, the pH was increased by the addition of
a half-volume of 100 mM sodium borate +100 mM sodium chloride (pH 9.1). After incubation for
1 h at room temperature, the biotinylated antibodies were separated from free biotin by gel filtration
on a Bio-gel P10 column (Bio-Rad, Hercules, CA, USA) or by using Zeba spin 7 K desalting columns
(Thermo Fisher, Waltham, MA, USA).
4.5. Surface Plasmon Resonance Evaluation of Anti-STX mAbs
Surface plasmon resonance (SPR) affinity and kinetics measurements were performed using the
ProteOn XPR36 (Bio-Rad). Lanes of a general layer compact (GLC) chip were individually coated
with STX covalently linked to an irrelevant HuIgG in 10 mM acetate buffer with pH 5.0. The covalent
crosslinking of STX protocol was described previously [15] and in Section 4.6. The STX-HuIgG
was attached to the chip following the standard 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDC)/N-hydroxysulfosuccinimide (Sulfo-NHS) coupling chemistry available from
the manufacturer. Binding kinetics of each antibody was tested at 25 ◦C by flowing six concentrations
varying from 100 to 0 nM at 100 µL/min for 90 s over the antigen coated chip and then monitoring
dissociation for 600 s. For comparison purposes, this data was analyzed using a global Langmuir fit.
4.6. Preparation Toxin-Coated MagPlex Microspheres
MagPlex microspheres were coated with DA by first reacting the surface carboxyls with ethylene
diamine (EDA) using the standard two step protocol, where 30 µL of the microspheres were washed
with 0.1 M sodium phosphate (pH 6.0) three times, and then activated using EDC and Sulfo-NHS
5 mg/mL each. After 20 min the microspheres were washed once with 0.1 M sodium phosphate
(pH 6.0) and once with PBS, then microspheres were resuspended in EDA (1 mg/mL) in PBS
and incubated overnight. The next day, the microspheres were washed three times with 0.1 M
2-(N-morpholino)ethanesulfonic acid buffer (MES) at pH 4.5. The microspheres were then coated with
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DA by adding a 2:1 EDC:DA ratio. The microspheres were incubated for 1 h and then washed three
times with PBS and stored in the dark at 4 ◦C.
Use of a different chemistry to bind STX to the microspheres was indicated by the immunogen
used to prepare the mAbs [15]. MagPlex microspheres (50 µL) coated with STX were prepared by
first coating two sets of microspheres with either a purified rabbit or human polyclonal IgG towards
irrelevant targets, using the standard protocol described above except they were washed into PBS
and then resuspended in 0.4 mL of PBS on the following day. The carbohydrates on the IgG were
activated by the addition of 22 µL sodium periodate (46 mM). The microspheres were incubated in
the dark for 1 h at room temperature, then washed three times with PBS. The PBS was removed
and the microspheres resuspended in 40 µL of 0.1 M sodium bicarbonate (pH 8.5) to which 5 µL of
STX (100 µg/mL) was added. The microspheres were incubated for 1 h and then 1 µL of sodium
cyanoborohydride (5 M in 1 M NaOH) was added. The reaction was allowed to proceed for 30 min
on ice. Then the microspheres were washed three times with PBS and then stored in 0.1 M sodium
phosphate (pH 6.0).
4.7. Assays
Competitive immunoassay dose response curves were performed first in buffer and then with
the spiked food samples. Briefly, added into a well of a 96-well microtiter plate was either a sample
containing 1000 ng/mL STX or 200 ng/mL DA such that after serial dilutions (1:4 for STX and 1:3 for
DA) 90 µL remained in each well. Next, 10 µL of the biotinylated scFvs (bt-anti-STX, 5F7, at 2.5 µg/mL
final for STX and bt-anti-DA at 10 µg/mL final) were added, followed with 10 µL of toxin-coated
beads. The foil-covered plate was placed on a FINEPCR micromixer MX4t (Gyeonggi-Do, Korea) for
30 min at room temperature. Using a 96-well flat magnetic plate (BioTek, Winooski, VT, USA), the
supernatant was removed and the beads were washed with PBSTB. For signal generation, 50 µL of
2.5 µg/mL SA-PE were added to each well and plate was incubated on shaker for 15 min followed by
a wash with PBSTB. Based on previous work which showed a ~5 fold increase in signal [50], a second
round of SA-PE was performed as follows. Fifty µL of biotinylated anti-SA (1 µg/mL) were added,
incubated for 15 min, and washed with PBSTB. Lastly, another 50 µL of 2.5 µg/mL SA-PE was added
and the mixture incubated for 15 min. The beads were washed 2× with PBSTB. PBSTB (100 µL) was
added to each well and the plate was analyzed with Luminex MAGPIX. For the assay using the intact
mAbs, only a single 30 min incubation with SA-PE (2.5 µg/mL) was performed. Percent inhibition
was calculated using the following equation:
100 − [(signal/(blank signal))× 100]
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/8/11/346/s1,
Figure S1: Percent inhibition dose response curves for saxitoxin and domoic acid. Figure S2: Dose response curves
for mixed saxitoxin and domoic acid assay in buffer.
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